ASSESSMENT OF PLACENTAL OXIDATIVE STRESS PARAMETERS IN PREECLAMPTIC AND NORMAL PREGNANT WOMEN

Authors

  • Kavitha V
  • SRINIVAS B kakatiya university
  • Praveen Kumar Mvln
  • Shashikanth P

Abstract

Objective: Oxidative stress occurs when cellular levels of reactive oxygen species exceed antioxidant capabilities and has been implicated in the
pathogenesis of pre-eclampsia. In this study, we examined the tissue levels of endogenous antioxidant enzymes or proteins (superoxide dismutase
[SOD], glutathione peroxidise, reduced glutathione, catalase, and thioredoxin) and the levels of lipid peroxides, protein carbonyls, hydrogen peroxide,
and nitrosative biomarkers in the placental samples from normal and pre-eclamptic pregnancies.
Results: Pre-eclamptic tissue homogenates demonstrated significantly increased levels of lipid peroxidation (21.61±0.18 vs. 5.695±0.46) and
a trended increase in protein carbonyls (245.95±4.05 vs. 203.48±3.65) concentration when compared to controls. The levels and activities of the
antioxidant proteins; SOD (365.2±2.915 vs. 205.6±3.76), thioredoxin (100.64±3.38 vs. 80.89±3.37), glutathione peroxidase (340.88±6.16 vs.
164.46±3.03), catalase (5.26±0.02 vs. 4.62±0.11), and reduced glutathione (46.99±0.508 vs. 28.19±0.178) were all found to be significantly reduced
when comparing pre-eclamptic placental tissue homogenates to gestational age matched control placentae from non pre-eclamptic pregnancies.
Conclusion: The results of this study demonstrate a decreased enzymatic antioxidant capacity and increased oxidation in placental tissue from preeclamptic
women,
which
may
contribute
to
the pathogenesis of this complex
disorder.
Keywords: Oxidative stress, Reactive oxygen species, Superoxide dismutase, Glutathione peroxidise, Reduced glutathione, Catalase, Thioredoxin,
Lipid peroxides and protein carbonyls.

Downloads

Download data is not yet available.

References

Brown MA, Hague WM, Higgins J. The Detection, Investigation and

Management of Hypertension in Pregnancy: Executive Summary

Council of the Australian Society of Hypertension in Pregnancy; 2000.

National High Blood Pressure Education Program Working Group on

High Blood Pressure in Pregnancy. Report of the National High Blood

Pressure Education Program Working Group on High Blood Pressure in

Pregnancy. Am J Obstet Gynecol 2000;183(1):S1-22.

Lowe SA, Brown MA, Dekker G, Gatt SM, McMahon L, Mangos G,

et al. Guidelines for the management of hypertensive disorders of

pregnancy. Soc Obstet Med Aust New Z 2008;49(3):242-6.

Fagermo N, Makonnen E,Debella A,Levinson,Jawetz E,Tsai CC.

Hypertensive Disorders of Pregnancy. Queensland: Statewide Maternity

and Neonatal Clinical Guidelines - Government of Queensland; 2010.

Available from: http://www.en.wikipedia.org/wiki/Preeclampsia#Epidemiology.

Asian J Pharm Clin Res, Vol 9, Issue 1, 2016, 105-109

Kavitha et al.

van Beck E, Peeters LL. Pathogenesis of preeclampsia: A comprehensive

model. Obstet Gynecol Surv 1998;53:233-9.

Wang Y, Alexander JS. Placental pathophysiology in preeclampsia.

Pathophysiology 2000;6:261-70.

Jónsdóttir LS, Arngrímsson R, Geirsson RT, Sigvaldason H,

Sigfússon N. Death rates from ischemic heart disease in women with

a history of hypertension in pregnancy. Acta Obstet Gynecol Scand

;74:772-6.

VanWijk MJ, Kublickiene K, Boer K, VanBavel E. Vascular function in

preeclampsia. Cardiovasc Res 2000;47:38-48.

Dekker GA. Risk factors for preeclampsia. Clin Obstet Gynecol

;42:422-35.

Available from: http://www.ncbi.nlm.nih.gov/pubmedhealth/

PMH0001900/, http://www.en.wikipedia.org/wiki/Pre-eclampsia.

Hung TH, Skepper JN, Charnock-Jones DS, Burton GJ. Hypoxiareoxygenation:

A

potent inducer of apoptotic changes

in the human

placenta

and

possible etiological

factor

in preeclampsia. Circ

Res

;90:1274-81.

Redman CW, Sargent IL. The pathogenesis of pre-eclampsia. Gynecol

Obstet Fertil 2001;29(7-8):518-22.

Ohlsson R, Glaser A, Holmgren L, Franklin G. The molecular biology

of placental development. In: Redman C, Sargent I, Starkey PM, editors.

The Human Placenta. Oxford: Blackwell Scientific Publications; 1993.

p. 33-81.

Seeley R, Stephens T, Tate T. Anatomy and Physiology. St. Louis:

Mosby; 1995.

Red-Horse K, Zhou Y, Genbacev O, Prakobphol A, Foulk R,

McMaster M, et al. Trophoblast differentiation during embryo

implantation and formation of the maternal-fetal interface. J Clin Invest

;114:744-54.

Genbacev O, Joslin R, Damsky CH, Polliotti BM, Fisher SL. Hypoxia

alters early gestation human cytotrophoblast differentiation/invasion in

vitro and models the placental defects that occur in preeclampsia. J Clin

Invest 1996;97:540-50.

Kaufmann P, Black S, Huppertz B. Endovascular trophoblast invasion:

Implications for the pathogenesis of intrauterine growth retardation and

preeclampsia. Biol Reprod 2003;69:1-7.

Zhou Y, Fisher SJ, Janatpour M, Genbacev O, Dejana E, Wheelock M,

et al. Human cytotrophoblasts adopt a vascular phenotype as they

differentiate. A strategy for successful endovascular invasion? J Clin

Invest 1997;99:2139-51. Zhou Y, Damsky CH, Fisher SJ. Preeclampsia

is associated with failure of human cytotrophoblasts to a mimic a

vascular adhesion phenotype one cause of defective endovascular

invasion in this syndrome? J Clin Invest 1997b;99:2152-64.

Published

01-01-2016

How to Cite

V, K., S. . B, P. K. Mvln, and S. P. “ASSESSMENT OF PLACENTAL OXIDATIVE STRESS PARAMETERS IN PREECLAMPTIC AND NORMAL PREGNANT WOMEN”. Asian Journal of Pharmaceutical and Clinical Research, vol. 9, no. 1, Jan. 2016, pp. 105-9, https://journals.innovareacademics.in/index.php/ajpcr/article/view/8948.

Issue

Section

Original Article(s)